Abstract:Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly 25% of the population and is the leading cause for liver-related mortality. Bariatric surgery is a well-known treatment for MASLD and obesity. Understanding the fundamental mechanisms by which bariatric surgery can alter MASLD can lead to new avenues of therapy and research. Previous studies have identified the microbiome's role in bariatric surgery and in inflammatory immune cell populations. The host innate immune system modulates hepatic inflammation and fibrosis, and thus the progression of MASLD. The precise role of immune cell types in the pathogenesis of MASLD remains an active area of investigation. The aim of this study was to understand the interplay between microbiota composition post-bariatric surgery and the immune system in MASLD. Methods: Eighteen morbidly obese females undergoing sleeve gastrectomy were followed pre-and post-surgery. Stool from four patients, showing resolved MASLD post-surgery with sustained weight loss, was transplanted into antibiotic treated mice. Mice received pre-or post-surgery stool and were fed a standard or high-fat diet. Bodyweight, food intake, and physiological parameters were tracked weekly. Metabolic parameters were measured post-study termination. Results: The human study revealed that bariatric surgery led to significant weight loss (p > 0.05), decreased inflammatory markers, and improved glucose levels six months post-surgery. Patients with weight loss of 20% or more showed distinct changes in blood metabolites and gut microbiome composition, notably an increase in Bacteroides. The mouse model confirmed surgery-induced microbiome changes to be a major factor in the reduction of markers and attenuation of MASLD progression. Mice receiving post-surgery fecal transplants had significantly less weight gain and liver steatosis compared to pre-surgery recipients. There was also a significant decrease in inflammatory cytokines interferon gamma, interleukin 2, interleukin 15, and mig. This was accompanied by alterations in liver immunophenotype, including an increase in natural killer T cells and reduction of Kupfer cells in the post-surgery transplant group. Discussion: Our findings suggest surgery induced microbial changes significantly reduce inflammatory markers and fatty liver progression. The results indicate a potential causal link between the microbiome and the host immune system, possibly mediated through modulation of liver NKT and Kupffer cells.

Multi-omics insights into the microbiota-gut-brain axis and cognitive improvement post-bariatric surgery

Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality

Bacterial and clinical metabolic signatures and their interactions in obese patients post-bariatric surgery

Gut Microbiota and Mycobiota Evolution Is Linked to Memory Improvement after Bariatric Surgery in Obese Patients: A Pilot Study

Impact of bariatric surgery on gut microbiota composition in obese patients compared to healthy controls

Changes in gut microbiota and cytokines following laparoscopic sleeve gastrectomy are associated with cognitive function improvement

Gut microbiome modified by bariatric surgery improves insulin sensitivity and correlates with increased brown fat activity and energy expenditure

Gut Microbiota, Probiotics and Psychological States and Behaviors after Bariatric Surgery—A Systematic Review of Their Interrelation

[Role and change of the gut microbiota after bariatric surgery].

Influence of Bariatric Surgery on Gut Microbiota Composition and Its Implication on Brain and Peripheral Targets

Gut microbiota in bariatric surgery

Bariatric Surgery and Gut-Brain-Axis Driven Alterations in Cognition and Inflammation

New mechanistic insights of anti-obesity by sleeve gastrectomy-altered gut microbiota and lipid metabolism

Multi-omic phenotyping reveals host-microbe responses to bariatric surgery, glycaemic control and obesity

Bariatric Surgery Improves Cognition Function in the Patients with Obesity: A Meta-Analysis

Microbiota dynamics preceding bariatric surgery as obesity treatment: a comprehensive review

Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system

Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery

The effects of bariatric surgery on cognition in patients with obesity: a systematic review and meta-analysis

Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

Reversal of Functional Brain Activity Related to Gut Microbiome and Hormones after VSG Surgery in Patients with Obesity